"# Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M: In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China. J Infect Chemother. 2000 Jun;6(2):81-5. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/11810540 # Iakovlev VP, Vishnevskii VA, Khlebnikov EP, Khadin IM, Plavlova MV, Elagina LV, Izotova GN: [Cefpiramide (Tamicin) in the treatment of purulent complications of abdominal surgery] Antibiot Khimioter. 1995 Sep;40(9):30-4. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/8651827 # Sampi K, Hattori M: [Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study] Gan To Kagaku Ryoho. 1992 Aug;19(9):1315-20. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1503486"@en . . . . "Adverse effects following overdosage include nausea, vomiting, epigastric distress, diarrhea, and convulsions."@en . " "@en . "The bactericidal activity of cefpiramide results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs)."@en . "Cefpiramide"@en . "Enteric bacteria and other eubacteria"@en . . . . . . . . " "@en . . . . . . . . . . . . . . . . . . . . . "For treatment of severe infections caused by susceptible bacteria such as P. aeruginosa."@en . . . "approved"@en . "Cefpiramido"@en . . "Rapidly absorbed following intramuscular injection."@en . "70797-11-4"@en . . . . "Cefpiramide is a third-generation cephalosporin antibiotic. "@en . "Cefpiramidum"@en . . "4.44 hours"@en . "Cefpiramide"@en . . .